A revolutionary class of drugs with the potential to treat intractable diseases like cancer and other killers — as well as to explode health spending globally — is at the center of the toughest negotiations of the biggest trade deal in history. The pharmaceutical industry has been pressing the Obama administratio...
Read more: http://ift.tt/1QCtvze
No comments:
Post a Comment